Literature DB >> 900919

Neutrophil toxicity of amphotericin B.

C J Chunn, P R Starr, D N Gilbert.   

Abstract

The toxicity of amphotericin B (AmB) for neutrophils and the protective effect of serum cholesterol were investigated. Neutrophils were exposed in vitro to varying concentrations of AmB. As judged by trypan blue exclusion, neutrophil viability decreased by 40% (P < 0.001) within 30 min of incubation in sterol-free buffer containing 5 mug of AmB per ml. In the presence of 4 mg of cholesterol per 100 ml in buffer, the AmB concentration could be increased to 50 mug/ml before significant (P < 0.01) neutrophil toxicity occurred. Hexose monophosphate shunt activity of neutrophils incubated in serum or cholesterol-containing buffer with 10 mug of AmB per ml was normal. These results suggest that serum contains a protective factor, probably cholesterol, which protects neutrophils in vitro from the toxic effects of AmB.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900919      PMCID: PMC429889          DOI: 10.1128/AAC.12.2.226

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

2.  Some aspects of the absorption, distribution, and excretion of amphotericin B in man.

Authors:  D B LOURIA
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1958-05

3.  Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B.

Authors:  B Björkstén; C Ray; P G Quie
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Amphotericin B and other polyenic antifungal antibiotics.

Authors:  J O Lampen
Journal:  Am J Clin Pathol       Date:  1969-08       Impact factor: 2.493

6.  Increased permeability of human erythrocytes induced by amphotericin B.

Authors:  W T Butler; E Cotlove
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

7.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

8.  Molecular aspects of polyene- and sterol-dependent pore formation in thin lipid membranes.

Authors:  V W Dennis; N W Stead; T E Andreoli
Journal:  J Gen Physiol       Date:  1970-03       Impact factor: 4.086

9.  Effects of amphotericin B on macrophages and their precursor cells.

Authors:  S H Lin; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

10.  The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B.

Authors:  A Cass; A Finkelstein; V Krespi
Journal:  J Gen Physiol       Date:  1970-07       Impact factor: 4.086

View more
  9 in total

1.  Enhancement of macrophage superoxide anion production by amphotericin B.

Authors:  E Wilson; L Thorson; D P Speert
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Amphotericin B is cytotoxic at locally delivered concentrations.

Authors:  Samuel Harmsen; Alex C McLaren; Christine Pauken; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

4.  Stimulation of human and canine neutrophil metabolism by amphotericin B.

Authors:  S R Supapidhayakul; L R Kizlaitis; B R Andersen
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

5.  Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

Authors:  T Vago; G Baldi; D Colombo; M Barbareschi; G Norbiato; F Dallegri; M Bevilacqua
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

6.  Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B.

Authors:  E J Bow; M L Schroeder; T J Louie
Journal:  Can Med Assoc J       Date:  1984-03-01       Impact factor: 8.262

7.  Pentoxifylline in amphotericin B toxicity rat model.

Authors:  K M Wasan; K Vadiei; G Lopez-Berestein; R R Verani; D R Luke
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

8.  Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function.

Authors:  D J Marmer; B T Fields; G L France; R W Steele
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

9.  Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.